Title : Cyclophosphamide bioactivation pharmacogenetics in breast cancer patients.

Pub. Date : 2021 Sep

PMID : 34114066






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 PURPOSE: Genetic variation in the activation of the prodrug cyclophosphamide (CP) by cytochrome P450 (CYP) enzymes has been shown to influence outcomes. Cyclophosphamide cytochrome P450 family 4 subfamily F member 3 Homo sapiens
2 PURPOSE: Genetic variation in the activation of the prodrug cyclophosphamide (CP) by cytochrome P450 (CYP) enzymes has been shown to influence outcomes. Cyclophosphamide cytochrome P450 family 4 subfamily F member 3 Homo sapiens